A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)
Completed · Phase 3
Conditions studied: Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis
In brief
The purpose of the study is to evaluate the ability of subjects with moderate to severe chronic plaque psoriasis (PSO) to safely and effectively self-inject bimekizumab at study start and 8 weeks after training in self-injection technique using a prefilled safety syringe or an auto-injector.
Key facts
- Study ID
- NCT03766685
- Run by
- UCB Biopharma SRL
- People needed
- 172
- Starts
- 2018-12-20
- Expected to finish
- 2020-09-08
- Last updated by the study team
- 2025-07-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject fulfills all inclusion criteria for the PS0014 [NCT03598790] study
- Subject is considered reliable and capable of adhering to the DV0002 protocol (eg, able to understand and complete questionnaires, willing to self-inject, able to use investigational device according to the instructions for use (IFU), and able to adhere to the visit schedule) according to the judgment of the Investigator
You may not qualify if…
- Subjects are not permitted to enroll in DV0002 if any of the PS0014 [NCT03598790] study exclusion criteria are met
Where it is running
- Dv0002 946 — Phoenix, Arizona, United States
- Dv0002 910 — Bakersfield, California, United States
- Dv0002 955 — San Diego, California, United States
- Dv0002 943 — San Luis Obispo, California, United States
- Dv0002 967 — Santa Monica, California, United States
- Dv0002 906 — Boca Raton, Florida, United States
- Dv0002 907 — Miami, Florida, United States
- Dv0002 903 — Ocala, Florida, United States
- Dv0002 936 — Tampa, Florida, United States
- Dv0002 941 — Alpharetta, Georgia, United States
- Dv0002 954 — Skokie, Illinois, United States
- Dv0002 900 — West Des Moines, Iowa, United States
- Dv0002 905 — Overland Park, Kansas, United States
- Dv0002 962 — Owensboro, Kentucky, United States
- Dv0002 922 — Baton Rouge, Louisiana, United States
- Dv0002 925 — Brighton, Massachusetts, United States
- Dv0002 917 — Troy, Michigan, United States
- Dv0002 915 — St Louis, Missouri, United States
- Dv0002 901 — Portsmouth, New Hampshire, United States
- Dv0002 908 — East Windsor, New Jersey, United States
- Dv0002 913 — New York, New York, United States
- Dv0002 963 — Rochester, New York, United States
- Dv0002 920 — Portland, Oregon, United States
- Dv0002 929 — Portland, Oregon, United States
- Dv0002 937 — Johnston, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.